Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

1.

Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis C.

Sasso M, Tengher-Barna I, Ziol M, Miette V, Fournier C, Sandrin L, Poupon R, Cardoso AC, Marcellin P, Douvin C, de Ledinghen V, Trinchet JC, Beaugrand M.

J Viral Hepat. 2012 Apr;19(4):244-53. doi: 10.1111/j.1365-2893.2011.01534.x. Epub 2011 Oct 13.

PMID:
22404722
[PubMed - indexed for MEDLINE]
2.

Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.

Myers RP, Pollett A, Kirsch R, Pomier-Layrargues G, Beaton M, Levstik M, Duarte-Rojo A, Wong D, Crotty P, Elkashab M.

Liver Int. 2012 Jul;32(6):902-10. doi: 10.1111/j.1478-3231.2012.02781.x. Epub 2012 Mar 21.

PMID:
22435761
[PubMed - indexed for MEDLINE]
3.

Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.

de Lédinghen V, Vergniol J, Foucher J, Merrouche W, le Bail B.

Liver Int. 2012 Jul;32(6):911-8. doi: 10.1111/j.1478-3231.2012.02820.x.

PMID:
22672642
[PubMed - indexed for MEDLINE]
4.

Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance?

Kumar M, Rastogi A, Singh T, Behari C, Gupta E, Garg H, Kumar R, Bhatia V, Sarin SK.

J Gastroenterol Hepatol. 2013 Jul;28(7):1194-201. doi: 10.1111/jgh.12134.

PMID:
23425053
[PubMed - indexed for MEDLINE]
5.

Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases.

Obara N, Ueno Y, Fukushima K, Nakagome Y, Kakazu E, Kimura O, Wakui Y, Kido O, Ninomiya M, Kogure T, Inoue J, Kondo Y, Shiina M, Iwasaki T, Yamamoto T, Shimosegawa T.

J Gastroenterol. 2008;43(9):720-8. doi: 10.1007/s00535-008-2225-2. Epub 2008 Sep 20.

PMID:
18807134
[PubMed - indexed for MEDLINE]
6.

Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C. Results from a cohort of 324 patients.

Lupşor M, Badea R, Stefănescu H, Grigorescu M, Sparchez Z, Serban A, Branda H, Iancu S, Maniu A.

J Gastrointestin Liver Dis. 2008 Jun;17(2):155-63.

PMID:
18568136
[PubMed - indexed for MEDLINE]
Free Article
7.

Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis.

Jazwinski AB, Thompson AJ, Clark PJ, Naggie S, Tillmann HL, Patel K.

J Viral Hepat. 2012 Apr;19(4):278-82. doi: 10.1111/j.1365-2893.2011.01546.x. Epub 2011 Nov 24.

PMID:
22404726
[PubMed - indexed for MEDLINE]
8.

Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population.

Chon YE, Jung KS, Kim SU, Park JY, Park YN, Kim do Y, Ahn SH, Chon CY, Lee HW, Park Y, Han KH.

Liver Int. 2014 Jan;34(1):102-9. doi: 10.1111/liv.12282. Epub 2013 Sep 13.

PMID:
24028214
[PubMed - indexed for MEDLINE]
9.

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.

Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, de Lédinghen V, Marcellin P, Dhumeaux D, Trinchet JC, Beaugrand M.

Hepatology. 2005 Jan;41(1):48-54.

PMID:
15690481
[PubMed - indexed for MEDLINE]
10.

Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard.

Poynard T, de Ledinghen V, Zarski JP, Stanciu C, Munteanu M, Vergniol J, France J, Trifan A, Le Naour G, Vaillant JC, Ratziu V, Charlotte F; Fibrosis-TAGS group.

J Hepatol. 2012 Mar;56(3):541-8. doi: 10.1016/j.jhep.2011.08.007. Epub 2011 Sep 1.

PMID:
21889468
[PubMed - indexed for MEDLINE]
11.

Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C.

Chen SH, Li YF, Lai HC, Kao JT, Peng CY, Chuang PH, Su WP, Chiang IP.

BMC Gastroenterol. 2012 Aug 10;12:105. doi: 10.1186/1471-230X-12-105.

PMID:
22877310
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan.

Sasso M, Miette V, Sandrin L, Beaugrand M.

Clin Res Hepatol Gastroenterol. 2012 Feb;36(1):13-20. doi: 10.1016/j.clinre.2011.08.001. Epub 2011 Sep 15. Review.

PMID:
21920839
[PubMed - indexed for MEDLINE]
13.

Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography.

Posthouwer D, Mauser-Bunschoten EP, Fischer K, VAN Erpecum KJ, DE Knegt RJ.

J Thromb Haemost. 2007 Jan;5(1):25-30.

PMID:
17239163
[PubMed - indexed for MEDLINE]
14.

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Castéra L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Darriet M, Couzigou P, De Lédinghen V.

Gastroenterology. 2005 Feb;128(2):343-50.

PMID:
15685546
[PubMed - indexed for MEDLINE]
15.

Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

Sasso M, Beaugrand M, de Ledinghen V, Douvin C, Marcellin P, Poupon R, Sandrin L, Miette V.

Ultrasound Med Biol. 2010 Nov;36(11):1825-35. doi: 10.1016/j.ultrasmedbio.2010.07.005. Epub 2010 Sep 27.

PMID:
20870345
[PubMed - indexed for MEDLINE]
16.

Controlled attenuation parameter for noninvasive assessment of hepatic steatosis using Fibroscan®: validation in chronic hepatitis B.

Mi YQ, Shi QY, Xu L, Shi RF, Liu YG, Li P, Shen F, Lu W, Fan JG.

Dig Dis Sci. 2015 Jan;60(1):243-51. doi: 10.1007/s10620-014-3341-x. Epub 2014 Sep 7.

PMID:
25194851
[PubMed - in process]
17.

Digital quantification is more precise than traditional semiquantitation of hepatic steatosis: correlation with fibrosis in 220 treatment-naïve patients with chronic hepatitis C.

Rawlins SR, El-Zammar O, Zinkievich JM, Newman N, Levine RA.

Dig Dis Sci. 2010 Jul;55(7):2049-57. doi: 10.1007/s10620-010-1254-x. Epub 2010 May 12.

PMID:
20458626
[PubMed - indexed for MEDLINE]
18.

Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: a meta-analysis of diagnostic accuracy.

Shi KQ, Tang JZ, Zhu XL, Ying L, Li DW, Gao J, Fang YX, Li GL, Song YJ, Deng ZJ, Wu JM, Tang KF.

J Gastroenterol Hepatol. 2014 Jun;29(6):1149-58. doi: 10.1111/jgh.12519.

PMID:
24476011
[PubMed - indexed for MEDLINE]
19.

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).

Yoneda M, Yoneda M, Mawatari H, Fujita K, Endo H, Iida H, Nozaki Y, Yonemitsu K, Higurashi T, Takahashi H, Kobayashi N, Kirikoshi H, Abe Y, Inamori M, Kubota K, Saito S, Tamano M, Hiraishi H, Maeyama S, Yamaguchi N, Togo S, Nakajima A.

Dig Liver Dis. 2008 May;40(5):371-8. Epub 2007 Dec 20.

PMID:
18083083
[PubMed - indexed for MEDLINE]
20.

Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers.

Sánchez-Conde M, Montes-Ramírez ML, Miralles P, Alvarez JM, Bellón JM, Ramírez M, Arribas JR, Gutiérrez I, López JC, Cosín J, Alvarez E, González J, Berenguer J.

J Viral Hepat. 2010 Apr;17(4):280-6. doi: 10.1111/j.1365-2893.2009.01180.x. Epub 2009 Sep 2.

PMID:
19732322
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk